av/hyloris--big.svg

COM:HYLORIS

Hyloris Pharmaceuticals

  • Stock

Last Close

5.80

22/11 16:35

Market Cap

327.60M

Beta: -

Volume Today

60.81K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '19
Jun '19
Mar '20
Jun '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
net income
-561K
-
-753K
34.22%
-1.26M
67.86%
-2.48M
96.04%
-4.12M
66.26%
-8.24M
100%
-1.67M
79.74%
-3.34M
100%
-2.47M
26.00%
-4.94M
100%
-3.41M
30.92%
-5.83M
70.71%
-3.32M
43.09%
-6.63M
100%
-4.56M
31.20%
-9.13M
100%
depreciation and amortization
29K
-
22K
24.14%
24K
9.09%
28K
16.67%
13K
53.57%
26K
100%
44K
69.23%
88K
100%
27.50K
68.75%
55K
100%
52K
5.45%
141K
171.15%
81.50K
42.20%
170K
108.59%
93K
45.29%
179K
92.47%
deferred income tax
-113K
-
stock based compensation
113K
-
130K
15.04%
130.50K
0.38%
130.50K
0%
157.50K
20.69%
157.50K
0%
137K
13.02%
143K
-
156.50K
-
113K
-
change in working capital
-143K
-
277K
293.71%
-1.32M
575.45%
3.42M
359.68%
-601.50K
117.59%
-1.83M
203.91%
213.50K
111.68%
1.05M
392.27%
-455K
143.29%
-1.68M
269.01%
-328.50K
80.43%
-1.70M
416.29%
883K
152.06%
2.62M
196.15%
-411K
115.72%
-435K
5.84%
accounts receivables
-915K
-
-1.83M
100%
-119K
93.50%
-238K
100%
149K
162.61%
298K
100%
-609.50K
304.53%
-2.56M
319.85%
417K
116.30%
834K
100%
-563.50K
167.57%
-1.13M
100%
inventory
accounts payables
-625K
-
1.76M
-
-769K
-
301K
-
849K
-
387K
-
other working capital
313.50K
-
627K
100%
332.50K
46.97%
-474K
242.56%
-604K
27.43%
-1.21M
100%
281K
123.26%
562K
100%
466K
17.08%
932K
100%
152.50K
83.64%
305K
100%
other non cash items
218K
-
113K
48.17%
1.44M
1,173.45%
-63K
104.38%
3.27M
5,285.71%
270.50K
91.72%
-1.12M
512.94%
-439K
60.70%
-1.10M
150.57%
498.50K
145.32%
18K
96.39%
131.50K
630.56%
-144K
209.50%
470.50K
426.74%
1.05M
124.02%
net cash provided by operating activities
-675K
-
-236K
65.04%
-2.44M
935.59%
2.54M
203.89%
-4.64M
282.79%
-9.28M
100%
-984K
89.40%
-1.97M
100%
-3.20M
62.63%
-7.67M
139.53%
-3.05M
60.23%
-7.37M
141.55%
-2.06M
71.97%
-3.99M
93.41%
-4.30M
7.65%
-8.33M
93.79%
investments in property plant and equipment
-35K
-
-568K
1,522.86%
-240K
57.75%
-247K
2.92%
-2K
99.19%
-154K
7,600%
-51.50K
66.56%
-907K
1,661.17%
-15K
98.35%
-212K
1,313.33%
-35.50K
83.25%
-527K
1,384.51%
-236K
-
-149K
36.86%
-487K
226.85%
acquisitions net
purchases of investments
-1.28M
-
-1.17M
-
-522K
-
22K
-
sales maturities of investments
3K
-
-3K
200%
other investing activites
-607K
-
219K
136.08%
-877K
500.46%
-877K
0%
-352K
59.86%
-5.54M
-
-44K
-
5.02M
-
9.97M
98.69%
net cash used for investing activites
-32K
-
-571K
1,684.38%
-240K
57.97%
-247K
2.92%
-609K
146.56%
-1.22M
100%
-928.50K
23.77%
-1.86M
100%
-367K
80.24%
-734K
100%
-5.58M
660.22%
-505K
90.95%
-44K
91.29%
-236K
436.36%
4.87M
2,163.98%
9.49M
94.76%
debt repayment
-13K
-
-13K
0%
-11K
15.38%
-8.06M
73,218.18%
-409K
-
-347K
-
-1.06M
-
-6.32M
-
-44K
-
-234K
-
common stock issued
17.17M
-
common stock repurchased
dividends paid
other financing activites
546K
-
-546K
200%
13.70M
2,609.52%
61.34M
347.70%
-217K
100.35%
-217K
0%
186K
185.71%
186K
0%
7.41M
3,881.18%
17.17M
131.86%
-3.49M
120.30%
-17.21M
393.78%
-40K
99.77%
-112K
180%
-54K
51.79%
114K
311.11%
net cash used provided by financing activities
533K
-
-559K
204.88%
13.69M
2,549.19%
53.28M
289.15%
-217K
100.41%
-434K
100%
186K
142.86%
372K
100%
7.41M
1,890.59%
16.07M
117.08%
-3.49M
121.69%
-6.36M
82.44%
-40K
99.37%
-68K
70%
-54K
20.59%
-120K
122.22%
effect of forex changes on cash
-1K
-
1K
200%
1K
0%
-1K
200%
-1K
-
-10M
-
net change in cash
-175K
-
-1.36M
680%
11.01M
906.45%
55.57M
404.81%
-5.47M
109.84%
-10.93M
100%
-1.73M
84.21%
-3.45M
100%
3.84M
211.14%
7.67M
100%
-12.12M
257.85%
-14.23M
17.46%
-2.15M
84.90%
-4.30M
100.05%
518.50K
112.06%
-8.96M
1,828.64%
cash at beginning of period
2.69M
-
2.51M
6.51%
205K
91.84%
11.21M
5,369.76%
64.40M
-
53.47M
16.98%
53.47M
0%
50.01M
-
57.69M
-
43.46M
-
39.16M
-
cash at end of period
2.51M
-
1.15M
54.34%
11.21M
877.59%
66.78M
495.59%
-5.47M
108.19%
53.47M
1,077.96%
51.74M
3.23%
50.01M
3.34%
3.84M
92.33%
57.69M
1,403.24%
-12.12M
121.00%
43.46M
458.70%
-2.15M
104.94%
39.16M
1,922.62%
518.50K
98.68%
30.20M
5,723.72%
operating cash flow
-675K
-
-236K
65.04%
-2.44M
935.59%
2.54M
203.89%
-4.64M
282.79%
-9.28M
100%
-984K
89.40%
-1.97M
100%
-3.20M
62.63%
-7.67M
139.53%
-3.05M
60.23%
-7.37M
141.55%
-2.06M
71.97%
-3.99M
93.41%
-4.30M
7.65%
-8.33M
93.79%
capital expenditure
-35K
-
-568K
1,522.86%
-240K
57.75%
-247K
2.92%
-2K
99.19%
-154K
7,600%
-51.50K
66.56%
-907K
1,661.17%
-15K
98.35%
-212K
1,313.33%
-35.50K
83.25%
-527K
1,384.51%
-236K
-
-149K
36.86%
-487K
226.85%
free cash flow
-710K
-
-804K
13.24%
-2.68M
233.83%
2.29M
185.39%
-4.64M
302.57%
-9.44M
103.23%
-1.04M
89.03%
-2.88M
177.64%
-3.22M
11.84%
-7.88M
145.00%
-3.08M
60.85%
-7.89M
155.86%
-2.06M
73.84%
-4.23M
104.84%
-4.45M
5.17%
-8.82M
98.25%

All numbers in (except ratios and percentages)